Open Insulin Foundation Aims to Revolutionize Diabetes Treatment with Affordable Open-Source Insulin.

Volunteer Scientists Target 98% Cost Reduction, Promising Relief for Millions.

The rising cost of insulin has long been a source of concern for individuals living with diabetes, particularly in the United States. In response to this crisis, the Open Insulin Foundation, a non-profit organization founded by Anthony di Franco, is leading the charge to provide an open-source and affordable model of insulin production. Their mission: to challenge the monopolized insulin market and make this life-saving medication accessible to those in need.

Driven by a dedicated team of volunteer scientists, the Open Insulin Foundation is taking on the formidable task of reverse engineering insulin to discover a cost-effective method of production. Their ambitious goal is to develop the world’s first open-source insulin production model and share their instructions freely with the world.

The foundation’s groundbreaking work has the potential to disrupt the current insulin market, where prices have skyrocketed by nearly 1,200% over the last quarter-century. Millions of people in the United States find themselves grappling with the financial burden of insulin, forcing some to ration their supply or go without it entirely.

According to the Open Insulin Foundation, their innovative approach could reduce insulin costs by a staggering 98%, making prices as low as $5-15 per vial a reality. This significant cost reduction would offer much-needed relief to individuals who have been struggling to afford this essential medication.

Media outlets such as Freethink and Interesting Engineering have featured the foundation’s groundbreaking work, shedding light on their mission to democratize insulin production and increase accessibility for all. Their efforts have struck a chord with the public and could potentially revolutionize diabetes treatment worldwide.

While the Open Insulin Foundation’s work is still in progress, its mission has already garnered significant attention and support. As they continue to pursue their goal of creating a more equitable insulin market, the foundation holds the promise of transforming the lives of millions of people by providing them with affordable access to this critical medication.







Leave a Reply

Your email address will not be published. Required fields are marked *